Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-29T19:14:50.017Z Has data issue: false hasContentIssue false
  • English
  • Français

Predictors of 10-year outcome of first-episode psychosis

Published online by Cambridge University Press:  03 February 2009

C. White ,
J. Stirling ,
R. Hopkins ,
J. Morris ,
L. Montague ,
D. Tantam  and
S. Lewis
C. White
Affiliation:
Division of Psychiatry, University of Manchester, Manchester, UK
J. Stirling*
Affiliation:
Department of Psychology and Speech Pathology, Manchester Metropolitan University, Manchester, UK
R. Hopkins
Affiliation:
Division of Psychiatry, University of Manchester, Manchester, UK
J. Morris
Affiliation:
Division of Psychiatry, University of Manchester, Manchester, UK
L. Montague
Affiliation:
Division of Psychiatry, University of Manchester, Manchester, UK
D. Tantam
Affiliation:
Centre for Mental Health, University of Sheffield, Sheffield, UK
S. Lewis
Affiliation:
Division of Psychiatry, University of Manchester, Manchester, UK
*
*Address for correspondence: J. Stirling, D.Phil., Department of Psychology and Speech Pathology, Manchester Metropolitan University, Hathersage Road, Manchester M13 0JA, UK. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Predictors of outcome for psychosis are poorly understood. Duration of untreated psychosis (DUP) appears to predict short-term outcome although its medium- to long-term role remains unclear. Neurodevelopmental indices such as pre-morbid function and/or neurological soft signs may predict longer-term outcome. We aimed to assess the impact of a range of clinical and demographic variables on long-term outcome of a geographically defined, epidemiological first-episode psychosis cohort.

Method

A 10-year follow-up was undertaken of a consecutively presenting sample of 109 cases of first-episode psychosis aged 16–50 years. Baseline assessments included positive, negative and depression symptoms, DUP, neurological soft signs and pre-morbid functioning. Multi-dimensional outcomes were assessed blind to baseline data.

Results

All participants were traced at a mean of 10.5 years post-index admission: 11 had died, 10 from non-natural causes. Of the surviving cases, 70% were comprehensively re-assessed by interview. Summary data on the remainder were collected from their family practitioner and chart review. Poor 10-year outcomes were predicted independently by poor pre-morbid functioning, baseline negative symptoms and longer DUP. The same measures, plus neurological soft signs, appeared to predict outcomes in a DSM-IV schizophrenia/schizo-affective subgroup.

Conclusions

Poor pre-morbid functioning, baseline symptoms, DUP and neurological soft signs at onset independently predict poor long-term outcome in first-episode psychosis.

Keywords

First-episode psychosislong-term follow-upoutcome predictors
Type
Original Articles
Information
Psychological Medicine , Volume 39 , Issue 9 , September 2009 , pp. 1447 - 1456
Copyright
Copyright © 2009 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, J, Van Mastrigt, S, Addington, D (2004). Duration of untreated psychosis: impact on two year outcome. Psychological Medicine 34, 277–284.CrossRefGoogle Scholar
Altamura, AC, Bassetti, R, Sassella, F, Salvadori, D, Mundo, E (2001). Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophrenia Research 52, 29–36.CrossRefGoogle ScholarPubMed
Andreasen, NC (1983). Scale for the Assessment of Negative Symptoms (SANS). University of Iowa: Iowa City.Google Scholar
Andreasen, NC (1984). Scale for Assessment of Positive Symptoms (SAPS). University of Iowa: Iowa City.Google Scholar
Andreasen, NC (1999). Understanding the causes of schizophrenia. New England Journal of Medicine 340, 645–647.CrossRefGoogle ScholarPubMed
Baldwin, P, Browne, D, Scully, PJ, Quinn, JF, Morgan, MG, Kinsella, A, Owens, JM, Russell, V, O'Callaghan, E, Waddington, JL (2005). Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 years. Schizophrenia Bulletin 31, 624–638.CrossRefGoogle Scholar
Barnes, TR, Hutton, SB, Chapman, MJ, Mutsatsa, S, Puri, BK, Joyce, EM (2000). West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. British Journal of Psychiatry 177, 207–211.CrossRefGoogle ScholarPubMed
Bilder, R, Reiter, G, Bates, J, Lencz, T, Szeszko, P, Goldman, R, Robinson, D, Lieberman, J, Kane, J (2006). Cognitive development in schizophrenia: follow-back from the first episode. Journal of Clinical and Experimental Neuropsychology 28, 270–282.CrossRefGoogle ScholarPubMed
Bombin, I, Arango, C, Buchanan, RW (2005). Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophrenia Bulletin 31, 962–977.CrossRefGoogle ScholarPubMed
Bottlender, R, Sato, T, Jager, R, Wegener, U, Wittmann, J, Strauss, A, Moller, HJ (2003). The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15 year outcome in schizophrenia. Schizophrenia Research 62, 37–44.CrossRefGoogle ScholarPubMed
Buchanan, RW, Heinrichs, DW (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research 27, 335–350.CrossRefGoogle Scholar
Cannon, TD, Van Erp, TG, Glahn, DC (2002). Elucidating continuities and discontinuities between schizotypy and schizophrenia in the nervous system. Schizophrenia Research 54, 151–156.CrossRefGoogle ScholarPubMed
Cannon-Spoor, HE, Potkin, SG, Wyatt, RJ (1982). Measurement of pre-morbid adjustment in chronic schizophrenia. Schizophrenia Bulletin 8, 470–484.CrossRefGoogle Scholar
Chen, EY, Hui, CL, Chan, R, Dunn, EL, Miao, M, Yeung, W, Wong, C, Chan, W, Tang, W (2005). A 3 year prospective study of neurological soft signs in first episode schizophrenia. Schizophrenia Research 75, 45–54.CrossRefGoogle ScholarPubMed
Drake, RJ, Haley, CJ, Akhtar, S, Lewis, SW (2000). Causes and consequences of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry 177, 511–515.CrossRefGoogle ScholarPubMed
Emsley, R, Turner, HJ, Oosthuizen, PP, Carr, J (2005). Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical outcome correlates. Schizophrenia Research 75, 35–44.CrossRefGoogle ScholarPubMed
Fenton, WS, McGlashan, TH (1991). Natural history of schizophrenia subtypes II. Positive and negative symptoms and long-term course. Archives of General Psychiatry 48, 978–986.CrossRefGoogle ScholarPubMed
Foerster, A, Lewis, SW, Owen, MJ, Murray, RM (1991). Pre-morbid adjustment and personality in psychosis: effects of sex and diagnosis. British Journal of Psychiatry 158, 171–176.CrossRefGoogle ScholarPubMed
Friis, S, Melle, I, Larsen, TK, Haahr, U, Johannessen, JO, Simonsen, E, Opjordsmoen, S, Vaglum, P, McGlashan, TH (2004). Does duration of untreated psychosis bias study samples of first-episode psychosis? Acta Psychiatrica Scandinavica 110, 286–291.CrossRefGoogle ScholarPubMed
Goldman, H, Skodol, AE, Lave, TR (1992). Revising axis V for DSM-IV: a review of measures of social functioning. American Journal of Psychiatry 149, 1148–1156.Google ScholarPubMed
Harrigan, SM, McGorry, PD, Krtsev, H (2003). Does treatment delay in first episode psychosis really matter? Psychological Medicine 33, 97–110.CrossRefGoogle ScholarPubMed
Harris, MG, Henry, LP, Harrigan, SM, Purcell, R, Schwartz, OS, Farrelly, SE, Prosser, AL, Jackson, HJ, McGorry, PD (2005). The relationship between duration of untreated psychosis and outcome: an eight year prospective study. Schizophrenia Research 79, 85–93.CrossRefGoogle ScholarPubMed
Harrison, G, Mason, P, Glazebrook, C, Medley, I, Croudace, T, Docherty, S (1994). Residence of incident cohort of psychotic patients after 13 years follow up. British Medical Journal 308, 813–816.CrossRefGoogle Scholar
Heinrichs, DW, Hanlon, TE, Carpenter, WE Jr. (1984). The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin 10, 388–398.CrossRefGoogle ScholarPubMed
Ho, BC, Andreasen, NC, Flaum, M, Napoulos, P, Miller, D (2000). Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. American Journal of Psychiatry 157, 163–171.CrossRefGoogle ScholarPubMed
Jarbin, H, Ott, Y, Von Knorring, A-L (2003). Adult outcome of social function in adolescent-onset schizophrenia and affective psychosis. Child and Adolescent Psychiatry 42, 176–183.CrossRefGoogle ScholarPubMed
Johannessen, JO, McGlashan, TH, Larsen, TK, Horneland, M, Joa, I, Mardal, S, Kvebaek, R, Friis, S, Melle, I, Opjordsmoen, S, Simonsen, E, Ulrik, H, Vaglum, P (2001). Early detection strategies for untreated first-episode psychosis. Schizophrenia Research 51, 39–46.CrossRefGoogle ScholarPubMed
Jones, P, Rodgers, B, Marmot, M, Murray, R (1994). Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 1398–1402.CrossRefGoogle ScholarPubMed
Kay, SR, Fisbein, A, Opler, LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.CrossRefGoogle ScholarPubMed
Keshavan, MS (1999). Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. Journal of Psychiatric Research 33, 513–521.CrossRefGoogle ScholarPubMed
Krstev, H, Carbone, S, Harrigan, S (2004). Early intervention in first episode psychosis: the impact of a community development campaign. Social Psychiatric Epidemiology 39, 711–719.CrossRefGoogle ScholarPubMed
Larsen, TK, Melle, I, Auestad, B, Friis, S, Haahr, U, Johannessen, JO, Opjordsmoen, S, Rund, BR, Simonsen, E, Vaglum, P, McGlashan, T (2006). Early detection of first episode psychosis: the effect on one year outcome. Schizophrenia Bulletin 32, 758–764.CrossRefGoogle Scholar
Larsen, TK, Moe, LC, Vibe-Hansen, L, Johannessen, JO (2000). Pre-morbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophrenia Research 45, 1–9.CrossRefGoogle Scholar
Leask, SJ, Done, DJ, Crow, TJ (2002). Adult psychosis, common childhood infections and neurological soft signs in a national birth cohort. British Journal of Psychiatry 181, 387–392.CrossRefGoogle Scholar
Lieberman, JA, Perkins, D, Belger, A, Chakos, M, Jarskog, F, Boteva, K, Gilmore, J (2001). The early stages of schizophrenia: speculations on pathogenesis, pathophysiology and therapeutic approaches. Biological Psychiatry 50, 884–897.CrossRefGoogle ScholarPubMed
Malla, A, Payne, J (2005). First episode psychosis: psychopathology, quality of life and functional outcome. Schizophrenia Bulletin 31, 650–671.CrossRefGoogle ScholarPubMed
Malla, AK, Norman, RM, Takhar, J, Manchanda, R, Townsend, L, Scholten, D, Haricharan, R (2004). Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis? Journal of Nervous and Mental Disease 192, 455–463.CrossRefGoogle ScholarPubMed
Marshall, M, Lewis, SW, Lockwood, A, Drake, RJ, Jones, PJ, Croudace, T (2005). The association between duration of untreated psychosis and outcome in cohorts of first episode patients. Archives of General Psychiatry 62, 975–983.CrossRefGoogle ScholarPubMed
McGlashan, TH (1999). Duration of untreated psychosis in first episode schizophrenia: marker or determinant of course? Biological Psychiatry 46, 899–907.CrossRefGoogle ScholarPubMed
McGorry, PD, Edwards, J, Hihalopoulos, C (1996). EPPIC: an evolving system of early detection and optimal management. Schizophrenia Bulletin 22, 305–306.CrossRefGoogle ScholarPubMed
Milev, P, Ho, BC, Arndt, S, Andreasen, N (2005). Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first episode study with 7 year follow-up. American Journal of Psychiatry 162, 495–506.CrossRefGoogle Scholar
Moller, HJ, Bottlender, R, Grosz, A, Hoff, P, Wittmann, J, Wegner, U, Strausz, A (2002). The Kraepelinian dichotomy: preliminary results of a 15 year follow-up study on functional psychosis: focus on negative symptoms. Schizophrenia Research 56, 87–94.CrossRefGoogle ScholarPubMed
Montague, LR, Tantam, D, Newby, D, Thomas, P, Ring, N (1989). The incidence of negative symptoms in early schizophrenia, mania and other psychoses. Acta Psychiatrica Scandinavica 79, 613–618.CrossRefGoogle ScholarPubMed
Montgomery, SA, Asberg, M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382–389.CrossRefGoogle ScholarPubMed
Pantelis, C, Velakoulis, D, McGorry, PD, Wood, SJ, Suckling, J, Phillips, LJ, Yung, A, Bullmore, ET, Brewer, W, Soulsby, B, Desmond, P, McGuire, PK (2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361, 281–288.CrossRefGoogle ScholarPubMed
Perkins, DO, Gu, H, Boteva, K, Lieberman, JA (2005). Relationship between duration of untreated psychosis and outcome in first episode schizophrenia: a critical review and meta-analysis. American Journal of Psychiatry 162, 1785–1804.CrossRefGoogle ScholarPubMed
Ring, N, Tantam, D, Montague, L, Morris, J (1991). Negative symptoms in chronic schizophrenia: relationship to duration of illness. British Journal of Psychiatry 159, 495–499.CrossRefGoogle ScholarPubMed
Ropcke, B, Eggers, C (2005). Early onset schizophrenia: a 15 year follow-up. European Child and Adolescent Psychiatry 14, 341–350.CrossRefGoogle ScholarPubMed
Rossi, A, DeCataldo, S, DiMichele, V, Manna, V, Ceccoli, S, Stratta, PC (1990). Neurological soft signs in schizophrenia. British Journal of Psychiatry 157, 735–739.CrossRefGoogle ScholarPubMed
Sartorious, N, Gulbinat, W, Harrison, G, Laska, E, Siegel, C (1996). Long-term follow-up of schizophrenia in 16 countries. Social Psychiatry and Psychiatric Epidemiology 31, 249–258.CrossRefGoogle Scholar
Scheffer, RE (2004). Abnormal neurological signs at the onset of psychosis. Schizophrenia Research 70, 19–26.CrossRefGoogle ScholarPubMed
Seigel, SJ, Irani, F, Brensinger, CM, Kohler, CG, Bilker, WB, Ragland, JD, Kanes, SJ, Gur, RC, Gur, RE (2006). Prognostic variables at intake and long-term level of function in schizophrenia. American Journal of Psychiatry 163, 433–441.CrossRefGoogle Scholar
Spitzer, RL, Endicott, J (1978). Diagnostic interview: the schedule for affective disorders and schizophrenia (SADS). Archives of General Psychiatry 35, 837–844.Google Scholar
Spitzer, RL, Endicott, J, Williams, JB (1979). Research diagnostic criteria. Archives of General Psychiatry 36, 1381–1383.CrossRefGoogle ScholarPubMed
Stirling, J, White, C, Lewis, SW, Hopkins, RS, Tantam, D, Huddy, A, Montague, L (2003). Neurocognitive function and outcome in first episode schizophrenia: a 10 year follow-up of an epidemiological cohort. Schizophrenia Research 65, 75–86.CrossRefGoogle ScholarPubMed
Van Os, J, Jones, P, Sham, P, Bebbington, P, Murray, RM (1998). Risk factors for onset and persistence of psychosis. Social Psychiatry and Psychiatric Epidemiology 33, 596–605.CrossRefGoogle ScholarPubMed
Verdoux, H, Liraud, F, Bergey, C, Assens, F, Abalan, F, Van Os, J (2001). Is the association between duration of untreated psychosis and outcome confounded? A two-year follow-up study of first-admitted patients. Schizophrenia Research 49, 231–241.CrossRefGoogle ScholarPubMed
Vourdas, A, Pipe, R, Corrigall, R, Frangou, S (2003). Increased developmental deviance and premorbid dysfunction in early onset schizophrenia. Schizophrenia Research 62, 13–22.CrossRefGoogle ScholarPubMed
Waddington, J, Sculley, P, Youssef, H (1997). Developmental trajectory and disease progression in schizophrenia: the conundrum and insights from a 12 year follow up study. Schizophrenia Research 23, 107–118.CrossRefGoogle Scholar
Wieselgren, IM, Lindstrom, LH (1996). A prospective 1–5 year outcome study in first-admitted and readmitted schizophrenic patients; relationship to heredity, pre-morbid adjustment, duration of disease and education level at index admission and neuroleptic treatment. Acta Psychiatrica Scandinavica 93, 9–19.CrossRefGoogle Scholar
Wing, JK, Cooper, JE, Sartorious, N (1974). The Measurement and Classification of Psychiatric Symptoms. Cambridge University Press: London.Google Scholar
WHO Collaborative Group (1992). Life Chart Schedule. WHO: Geneva.Google Scholar